Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm
Management Changes
Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm
Management Changes
Johnson & Johnson Targets Accelerated Growth Across Segments in 2026
JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit
Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know
Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus
J&J Adds $63B in Market Cap in 3 Months: Time to Buy the Stock?
Product StageAcquisitionFDA approved/pending approval
J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why
Product StageCustomers
Commentary: Trump’s trade war is hurting most sectors of the economy
Customers
J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?
[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
US-EU trade deal impacts on pharma industry more 'manageable' than expected
TEVA Q2 Earnings Beat, Revenues Miss on Lower Generics Sales
Product StagePartnersCustomers
Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?
TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock?
Product StagePartnersCustomers
J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?
Product StageAcquired-by
Pharma giant adds Israel to list of Middle East markets after omission raises questions
Customers
Bank Bonds That Cut Risk Draw Ares and Blackstone: Credit Weekly
InvestmentPartners
J&J Weighs Third Bankruptcy Try to Settle Baby Powder Suits
J&J to close Tel Hashomer blood bank operations
Layoffs
